Proprietary comp report by Overheard on Wall Street.
Harvard's endowment got rekt by private equity and hedge funds, but private equity professionals expect double-digit raises in 2024.
Private equity and venture capital firms from Silicon Valley to Wall Street are pumping millions of dollars into the psychedelic revolution. Investors are betting on the power of mind-bending drugs to transform mental health treatment and cut costs.
Plus: Zelle sued for fraud, Goldman thinks pro teams are too expensive for billionaires, private credit market could hit $40T in 2030, and RFK Jr. spotted in jeans at NYC Equinox.
Cryptocurrencies may be well suited to trend-following approaches.
Plus: M&A volume hit $3T in 2024, Luigi Mangione was hit with a federal murder charge, facing death penalty, and Blackstone dropped a holiday video (country) banger.
Plus: Barclays boosting bonuses by 20%, Grammarly bought Coda, Americans under 40 are richer than ever and miserable, and you can call and text ChatGPT now.
Plus: Brace yourselves, rate cuts are coming today. Nissan and Honda are in merger talks, Databricks raised $10 billion in VC funding, and how much Elon is making from DOGE.
Plus: Nvidia enters correction territory, Fed expected to announce one final rate cut tomorrow, Bitcoin moons above $107k, and the inexpensive watch with Rolex DNA.
Plus: Broadcom becomes a $1 trillion company, SEC charged Cantor Fitzgerald, OpenAI whistleblower is dead, and MicroStrategy will join the Nasdaq 100.
Firing on all cylinders.
Plus: Bezos matched Zuck's $1M contribution to Trump. Buzzfeed sold Hot Ones for $82M, Stanley will recall 2.6 million mugs, and Carlyle done with luxury bets.
Plus: Nasdaq hit 20,000, Luigi Mangione support fundraisers were yanked, Macy's gave update on employee who hid $151M, and Zuck gave $1 million to Trump.
Plus: Insurance stocks get rekt after the UNH saga. "These parasites had it coming," wrote the killer. Trump vowed rewards for $1B+ US investments, and Spotify's ascent to $100B.
Public & Private Markets Month-in-Review.